cell

Seagen and LAVA Therapeutics Announce Exclusive Worldwide License Agreement to Advance LAVA-1223, a Preclinical Gamma Delta Bispecific T Cell Engender for EGFR Expressing Solid Tumors

Seagen and LAVA Therapeutics Announce Exclusive Worldwide License Agreement to Advance LAVA-1223, a Preclinical Gamma Delta Bispecific T Cell Engender for EGFR Expressing Solid Tumors

– Seagen will develop and commercialize LAVA-1223, a bispecific T-cell engager designed to target and activate Vγ9Vδ2 (Gamma Delta) T cells in the presence of EGFR-expressing solid tumors – – LAVA will receive an upfront payment of $50 million, with potential milestones of up to approximately $650 million and royalties– – Seagen also has the …

Seagen and LAVA Therapeutics Announce Exclusive Worldwide License Agreement to Advance LAVA-1223, a Preclinical Gamma Delta Bispecific T Cell Engender for EGFR Expressing Solid Tumors Read More »

Cell Rover: Explore and augment the inner world of the cell

Cell Rover: Explore and augment the inner world of the cell

Researchers at MIT Media Lab have designed a miniature antenna that can operate wirelessly inside a living cell, opening up possibilities for medical diagnosis and treatment and other scientific processes due to the antenna’s potential to monitor and even direct cellular activity in real time. “The most exciting aspect of this research is that we …

Cell Rover: Explore and augment the inner world of the cell Read More »